Vascular Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Vascular Grafts Pipeline Market Report Overview

Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. They are the implants used to repair, bypass, or replace sections of blood vessels during surgical procedures. Vascular grafts are classified into autografts, allografts, and synthetic vascular grafts based on the materials.

The vascular grafts pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       United States

·       Europe

·       China

·       India

Key Segments ·       Peripheral Vascular Grafts

·       Aortic Vascular Grafts

Key Regulatory Paths ·       PMA

·       510(k)

·       CE

·       BLA

·       NMPA

Leading Companies ·       3DT Holdings LLC

·       Andes University

·       Angiograft LLC

·       Aquedeon Medical Inc

·       Ariste Medical LLC

Enquire & Decide

Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Vascular Grafts Pipeline Market Segmentation by Territories

A few of the key territories for vascular grafts pipeline products are the US, Europe, China, and India among others. As of June 2024, the US accounts for the highest number of pipeline products.

Vascular Grafts Pipeline Market Analysis by Territories, 2024 (%)

Vascular Grafts Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Vascular Grafts Pipeline Market

Download a Free Report Sample

Vascular Grafts Pipeline Market – Key Segments

A few of the key segments in the vascular grafts pipeline market are peripheral vascular grafts and aortic vascular grafts. As of June 2024, the peripheral vascular grafts segment has the highest number of pipeline products.

Vascular Grafts Pipeline Market Analysis by Segments, 2024 (%)

Vascular Grafts Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Vascular Grafts Pipeline Market

Download a Free Report Sample

Vascular Grafts Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Vascular Grafts pipeline market are PMA, 510(k), CE, BLA, and NMPA among others. As of June 2024, PMA is the most followed pathway for pipeline products in the market.

Vascular Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Vascular Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Vascular Grafts Pipeline Market

Download a Free Report Sample

Vascular Grafts Pipeline Market – Competitive Landscape

A few of the key companies associated with the vascular grafts pipeline market are 3DT Holdings LLC, Andes University, Angiograft LLC, Aquedeon Medical Inc, and Ariste Medical LLC among others.

3DT Holdings LLC: It is a contract research organization that offers drug development and manufacturing services. It develops, manufactures, and markets drugs for the treatment of cardiovascular, metabolic disorders, diabetes, and vascular diseases.

Vascular Grafts Pipeline Market Analysis by Companies, 2024

Vascular Grafts Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Vascular Grafts Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Vascular Grafts Pipeline Market Territories Outlook

  • United States
  • Europe
  • Global
  • China
  • India

Vascular Grafts Pipeline Market Regulatory Paths Outlook

  • PMA
  • 510(k)
  • CE
  • BLA
  • NMPA

Scope

This report provides:

  • Extensive coverage of the vascular grafts under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of vascular grafts and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Vascular Grafts under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3DT Holdings LLC
Andes University
Angiograft LLC
Aquedeon Medical Inc
Ariste Medical LLC
Artivion Inc
Aruga Technologies LLC
BioDGraft GmbH
BioIntegral Surgical Inc
Biosurfaces Inc
Cardiojustable LLC (Inactive)
Cardiovate
Colorado Therapeutics, LLC
Cytograft Tissue Engineering Inc (Inactive)
DSM Biomedical BV
Eqalix, Inc.
FIT Biotech Oy (Inactive)
Gel-Del Technologies, Inc.
Hannover Medical School
Humacyte Inc
Innovia LLC
Merit Medical Systems Inc
MicroPort Scientific Corp
Nationwide Children's Hospital
Northwestern University
Peca Labs Inc
PetVivo Holdings Inc
PQ Bypass Inc
RegenaGraft
RUA Vascular Ltd
Secant Group LLC
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Southern University of Science and Technology
Stanford University
STENTiT BV
Tgen Tech LLC
Transmural systems LLC
TTK Healthcare Ltd
University of Louisville
University of Nebraska Medical Center
University of Pittsburgh
Vascudyne Inc
VenoStent Inc
VesselTek BioMedical LLC
VESSL Therapeutics Ltd
Vygon SA
Xeltis AG
Yale University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 10

2 Introduction 11

2.1 Vascular Grafts Overview 11

3 Products under Development 12

3.1 Vascular Grafts – Pipeline Products by Stage of Development 12

3.2 Vascular Grafts – Pipeline Products by Segment 13

3.3 Vascular Grafts – Pipeline Products by Territory 14

3.4 Vascular Grafts – Pipeline Products by Regulatory Path 15

3.5 Vascular Grafts – Pipeline Products by Estimated Approval Date 16

3.6 Vascular Grafts – Ongoing Clinical Trials 17

4 Vascular Grafts – Pipeline Products under Development by Companies 18

4.1 Vascular Grafts Companies – Pipeline Products by Stage of Development 18

4.2 Vascular Grafts – Pipeline Products by Stage of Development 20

5 Vascular Grafts Companies and Product Overview 22

5.1 3DT Holdings LLC Company Overview 22

5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Andes University Company Overview 24

5.2.1 Andes University Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Angiograft LLC Company Overview 25

5.3.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Aquedeon Medical Inc Company Overview 26

5.4.1 Aquedeon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Ariste Medical LLC Company Overview 29

5.5.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Artivion Inc Company Overview 30

5.6.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 Aruga Technologies LLC Company Overview 31

5.7.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 BioDGraft GmbH Company Overview 32

5.8.1 BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 BioIntegral Surgical Inc Company Overview 33

5.9.1 BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Biosurfaces Inc Company Overview 34

5.10.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Cardiojustable LLC (Inactive) Company Overview 35

5.11.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Cardiovate Company Overview 36

5.12.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Colorado Therapeutics, LLC Company Overview 37

5.13.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Cytograft Tissue Engineering Inc (Inactive) Company Overview 38

5.14.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 DSM Biomedical BV Company Overview 40

5.15.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Eqalix, Inc. Company Overview 41

5.16.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41

5.17 FIT Biotech Oy (Inactive) Company Overview 43

5.17.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 Gel-Del Technologies, Inc. Company Overview 45

5.18.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Hannover Medical School Company Overview 46

5.19.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 Humacyte Inc Company Overview 47

5.20.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 Innovia LLC Company Overview 52

5.21.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.22 Merit Medical Systems Inc Company Overview 53

5.22.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.23 MicroPort Scientific Corp Company Overview 54

5.23.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 54

5.24 Nationwide Children’s Hospital Company Overview 55

5.24.1 Nationwide Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 55

5.25 Northwestern University Company Overview 58

5.25.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 58

5.26 Peca Labs Inc Company Overview 59

5.26.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.27 PetVivo Holdings Inc Company Overview 60

5.27.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.28 PQ Bypass Inc Company Overview 61

5.28.1 PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.29 RegenaGraft Company Overview 64

5.29.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 64

5.30 RUA Vascular Ltd Company Overview 65

5.30.1 RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

5.31 Secant Group LLC Company Overview 68

5.31.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview 68

5.32 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview 69

5.32.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.33 Southern University of Science and Technology Company Overview 72

5.33.1 Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 72

5.34 Stanford University Company Overview 73

5.34.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 73

5.35 STENTiT BV Company Overview 74

5.35.1 STENTiT BV Pipeline Products & Ongoing Clinical Trials Overview 74

5.36 Tgen Tech LLC Company Overview 75

5.36.1 Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview 75

5.37 Transmural systems LLC Company Overview 76

5.37.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.38 TTK Healthcare Ltd Company Overview 77

5.38.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 77

5.39 University of Louisville Company Overview 78

5.39.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 78

5.40 University of Nebraska Medical Center Company Overview 79

5.40.1 University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview 79

5.41 University of Pittsburgh Company Overview 80

5.41.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 80

5.42 Vascudyne Inc Company Overview 81

5.42.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.43 VenoStent Inc Company Overview 82

5.43.1 VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.44 VesselTek BioMedical LLC Company Overview 85

5.44.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.45 VESSL Therapeutics Ltd Company Overview 86

5.45.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 86

5.46 Vygon SA Company Overview 87

5.46.1 Vygon SA Pipeline Products & Ongoing Clinical Trials Overview 87

5.47 Xeltis AG Company Overview 88

5.47.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 88

5.48 Yale University Company Overview 89

5.48.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 89

6 Vascular Grafts- Recent Developments 90

6.1 May 22, 2024: MicroPort Announces Board and Committee Lineup 90

6.2 Apr 13, 2024: Atrium Medical Receives Additional FDA 510(k) Clearance for Flixene IFG Vascular Grafts With Assisted Delivery 90

6.3 Apr 10, 2024: Atrium Medical Receives FDA 510(k) Clearance for Advanta VXT Vascular Graft 90

6.4 Mar 19, 2024: PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis 90

6.5 Mar 18, 2024: Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System 91

6.6 Mar 11, 2024: W. L. Gore & Associates Receives Additional 510(K) Clearance For GORE PROPATEN Vascular Graft 92

6.7 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 92

6.8 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 92

6.9 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 92

6.10 Feb 09, 2024: Human Acellular Vessel (HAV) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma 93

6.11 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 93

6.12 Jan 29, 2024: W. L. Gore & Associates Additional 510(K) Clearance For GORE PROPATEN Vascular Graft 95

6.13 Jan 29, 2024: Peca Labs Receives Additional FDA 510(k) Clearance for exGraft ePTFE Vascular Graft 95

6.14 Jan 29, 2024: Peca Labs Receives Additional 510(K) Clearance For exGraft Carbon ePTFE Vascular Graft 96

6.15 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 96

6.16 Dec 20, 2023: RUA Life Sciences : Heart Valve Leaflet Material – Testing Update 96

6.17 Dec 12, 2023: Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel (HAV) for the Treatment of Vascular Trauma 97

6.18 Nov 20, 2023: RUA Life Sciences Announces Strategy Update 98

6.19 Nov 17, 2023: Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel (HAV) in the Treatment of Vascular Trauma 99

6.20 Nov 10, 2023: Microport Appointment of Director 100

6.21 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 101

6.22 Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results 103

6.23 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report 103

6.24 Sep 18, 2023: Humacyte to Host In-Person Kol Event at the New York Edition on September 20, 2023 106

6.25 Sep 12, 2023: Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel (HAV) in Treatment of Patients with Vascular Trauma 106

6.26 Sep 11, 2023: Results From Mayo Clinic Clinical Study of Humacyte’s Human Acellular Vessel (HAV) in Treatment of Patients with Chronic Limb Ischemia Presented at Midwestern Vascular Conference 107

6.27 Sep 11, 2023: Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel (HAV) Tuesday, September 12, 2023 at 8:00 AM ET 108

6.28 Aug 23, 2023: Aquedeon Medical, Receives FDA IDE Approval For The Duett Vascular Graft System 109

6.29 Aug 15, 2023: Humacyte Presents Clinical Performance of Human Acellular Vessel (HAV) From Ukrainian Humanitarian Program 109

6.30 Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference 110

6.31 Aug 03, 2023: Humacyte Announces Publication of Biological Mechanism Explaining Low Rates of Infection Observed in Clinical Study of Human Acellular Vessel (HAV) 111

6.32 Jul 26, 2023: Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel (HAV) for Vascular Trauma Repair 111

6.33 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 112

6.34 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 112

7 Appendix 113

7.1 Methodology 113

7.2 About GlobalData 116

7.3 Contact Us 116

7.4 Disclaimer 116

Table

Vascular Grafts – Pipeline Products by Stage of Development 12

Vascular Grafts – Pipeline Products by Segment 13

Vascular Grafts – Pipeline Products by Territory 14

Vascular Grafts – Pipeline Products by Regulatory Path 15

Vascular Grafts – Pipeline Products by Estimated Approval Date 16

Vascular Grafts – Ongoing Clinical Trials 17

Vascular Grafts Companies – Pipeline Products by Stage of Development 18

Vascular Grafts – Pipeline Products by Stage of Development 20

3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 22

PVP Biological Patch – Product Status 22

PVP Biological Patch – Product Description 22

Small Peripheral Vessel Graft – Product Status 23

Small Peripheral Vessel Graft – Product Description 23

Andes University Pipeline Products & Ongoing Clinical Trials Overview 24

SiSgraft – Product Status 24

SiSgraft – Product Description 24

Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 25

Vascular Graft – Product Status 25

Vascular Graft – Product Description 25

Aquedeon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Duett Vascular Graft System – Product Status 26

Duett Vascular Graft System – Product Description 26

Aquedeon Medical Inc – Ongoing Clinical Trials Overview 27

Duett Vascular Graft System – A Pivotal Study of Duett Vascular Graft System 28

Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29

Drug Eluting Vascular Graft – Product Status 29

Drug Eluting Vascular Graft – Product Description 29

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Synergraft Xenograft Vascular Graft – Product Status 30

Synergraft Xenograft Vascular Graft – Product Description 30

Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 31

Topograft – Product Status 31

Topograft – Product Description 31

BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview 32

Biodegradable Graft – Arteriosclerosis – Product Status 32

Biodegradable Graft – Arteriosclerosis – Product Description 32

BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Non-valved Conduit – Product Status 33

Non-valved Conduit – Product Description 33

Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 34

BioFunc – APC Vascular Graft – Product Status 34

BioFunc – APC Vascular Graft – Product Description 34

Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

Adjustable SPA Shunt – Product Status 35

Adjustable SPA Shunt – Product Description 35

Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 36

NeoVessel Vascular Graft – Product Status 36

NeoVessel Vascular Graft – Product Description 36

Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Xenograft Implant – Peripheral Vascular Disease – Product Status 37

Xenograft Implant – Peripheral Vascular Disease – Product Description 37

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

Lifeline TEBV – Lower Limb – Product Status 38

Lifeline TEBV – Lower Limb – Product Description 38

LifeLine TEBV – Pediatric – Product Status 39

LifeLine TEBV – Pediatric – Product Description 39

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 40

Small Diameter Vascular Graft – Product Status 40

Small Diameter Vascular Graft – Product Description 40

Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41

CardioVessel – Product Status 41

CardioVessel – Product Description 41

LCL Graft – Product Status 42

LCL Graft – Product Description 42

FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43

GTU X-Graft – Product Status 43

GTU X-Graft – Product Description 43

GTU X2-Graft – Product Status 44

GTU X2-Graft – Product Description 44

Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45

VasoGraft – Product Status 45

VasoGraft – Product Description 45

Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 46

Bioartificial Vascular Graft – Product Status 46

Bioartificial Vascular Graft – Product Description 46

Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Humacyl Graft – CABG – Product Status 47

Humacyl Graft – CABG – Product Description 47

Humacyl Graft – Critical Limb Ischemia – Product Status 48

Humacyl Graft – Critical Limb Ischemia – Product Description 48

Humacyl Graft – Peripheral Artery Disease – Product Status 48

Humacyl Graft – Peripheral Artery Disease – Product Description 49

Human Acellular Vessel – Vascular Trauma – Product Status 49

Human Acellular Vessel – Vascular Trauma – Product Description 49

Humacyte Inc – Ongoing Clinical Trials Overview 50

Human Acellular Vessel – Vascular Trauma – A Compassionate Use Study of Humacyte’s Human Acellular Vessel for the Treatment of Patients with Critical Limb Ischemia and Vascular Trauma 51

Human Acellular Vessel – Vascular Trauma – A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma 51

Human Acellular Vessel – Vascular Trauma – An Observational Multicenter Study to Evaluate the Safety and Efficacy of Humacyte’s Human Acellular Vessel in a Real World Setting for Arterial Replacement or Reconstruction in Ukrainian Patients with Life or Limb-threatening Vascular Trauma 51

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 52

4mm Vascular Graft – Product Status 52

4mm Vascular Graft – Product Description 52

Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Self-expanding Covered Stent Graft – Product Status 53

Self-expanding Covered Stent Graft – Product Description 53

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 54

Coronary Stent Graft System – Product Status 54

Coronary Stent Graft System – Product Description 54

Nationwide Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 55

Second-Generation Tissue Engineered Vascular Graft – Product Status 55

Second-Generation Tissue Engineered Vascular Graft – Product Description 55

Nationwide Children’s Hospital – Ongoing Clinical Trials Overview 56

Second-Generation Tissue Engineered Vascular Graft – Prospective, Open-labelled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection 57

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 58

ePTFE Graft – Peripheral Arterial Disease – Product Status 58

ePTFE Graft – Peripheral Arterial Disease – Product Description 58

Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59

exGraft II – Product Status 59

exGraft II – Product Description 59

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Peripheral Vascular Graft – Product Status 60

Peripheral Vascular Graft – Product Description 60

PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview 61

TORUS Stent Graft System – Product Status 61

TORUS Stent Graft System – Product Description 61

PQ Bypass Inc – Ongoing Clinical Trials Overview 62

TORUS Stent Graft System – The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization – 2 Trial: TORUS 2 63

RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 64

RegenaVasc – Product Status 64

RegenaVasc – Product Description 64

RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

Elast-Eon – Critical Limb Ischemia – Product Status 65

Elast-Eon – Critical Limb Ischemia – Product Description 65

Elast-Eon – Peripheral Artery Disease – Product Status 66

Elast-Eon – Peripheral Artery Disease – Product Description 66

Elast-Eon Large Bore Vascular Graft – Product Status 66

Elast-Eon Large Bore Vascular Graft – Product Description 67

Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Regenerez Graft – Product Status 68

Regenerez Graft – Product Description 68

Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

TIPS Stent Graft System – Product Status 69

TIPS Stent Graft System – Product Description 69

Shanghai MicroPort Endovascular MedTech Group Co Ltd – Ongoing Clinical Trials Overview 70

TIPS Stent Graft System – A Prospective, Multicenter, Single-group, Target-value Trial to Evaluate the Safety and Efficacy of Tips Coated Stent System in the Treatment of Portal Hypertension 71

Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 72

Artificial Blood Vessel – Product Status 72

Artificial Blood Vessel – Product Description 72

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 73

SDF-Eluting Vascular Conduit – Product Status 73

SDF-Eluting Vascular Conduit – Product Description 73

STENTiT BV Pipeline Products & Ongoing Clinical Trials Overview 74

Regenerative Stent – Product Status 74

Regenerative Stent – Product Description 74

Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview 75

TxGuard – Product Status 75

TxGuard – Product Description 75

Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 76

Transcatheter Cavopulmonary Bypass Endograft – Product Status 76

Transcatheter Cavopulmonary Bypass Endograft – Product Description 76

TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 77

Chitra Vascular Graft – Product Status 77

Chitra Vascular Graft – Product Description 77

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 78

Vascular Graft System – Product Status 78

Vascular Graft System – Product Description 78

University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview 79

Cardiac Vascular Access Graft – Product Status 79

Cardiac Vascular Access Graft – Product Description 79

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 80

Biomimetic Vascular Graft – Product Status 80

Biomimetic Vascular Graft – Product Description 80

Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview 81

TRUE Graft for Coronary Artery Bypass – Product Status 81

TRUE Graft for Coronary Artery Bypass – Product Description 81

VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview 82

SelfWrap – Product Status 82

SelfWrap – Product Description 82

VenoStent Inc – Ongoing Clinical Trials Overview 83

SelfWrap – Feasibility Study to Evaluate the Safety and Efficacy of VenoStent SelfWrap in End-stage Renal Disease Patients 84

SelfWrap – SAVE-Fistulas: The SelfWrap-Assisted Arteriovenous Fistulas Study 84

VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 85

VTek Graft – Product Status 85

VTek Graft – Product Description 85

VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 86

MultiGeneGraft – Product Status 86

MultiGeneGraft – Product Description 86

Vygon SA Pipeline Products & Ongoing Clinical Trials Overview 87

Vygon Vascular Graft – Product Status 87

Vygon Vascular Graft – Product Description 87

Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 88

Endogenous Tissue Restoration (ETR) Cardiovascular Graft – Product Status 88

Endogenous Tissue Restoration (ETR) Cardiovascular Graft – Product Description 88

Yale University Pipeline Products & Ongoing Clinical Trials Overview 89

Human iPSC-based Tissue Engineered Vascular Graft – Product Status 89

Human iPSC-based Tissue Engineered Vascular Graft – Product Description 89

Glossary 115

Figures

Vascular Grafts – Pipeline Products by Stage of Development 12

Vascular Grafts – Pipeline Products by Segment 13

Vascular Grafts – Pipeline Products by Territory 14

Vascular Grafts – Pipeline Products by Regulatory Path 15

Vascular Grafts – Pipeline Products by Estimated Approval Date 16

Vascular Grafts – Ongoing Clinical Trials 17

Frequently asked questions

Vascular Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Vascular Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Vascular Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Vascular Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.